111 related articles for article (PubMed ID: 1099159)
1. Regression of cutaneous neoplasms following delayed-type hypersensitivity challenge reactions to microbial antigens or lymphokines.
Holtermann OA; Papermaster B; Rosner D; Milgrom H; Klein E
J Med; 1975; 6(2):157-68. PubMed ID: 1099159
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapeutic approaches to the management of neoplasms.
Klein E; Holtermann OA
Natl Cancer Inst Monogr; 1972 Dec; 35():379-402. PubMed ID: 4572833
[No Abstract] [Full Text] [Related]
3. Nonspecific antigen reactions.
Klein E; Rosner D; Holtermann OA; Stoll HL; Song SY
Natl Cancer Inst Monogr; 1976 Nov; 44():87-97. PubMed ID: 799764
[TBL] [Abstract][Full Text] [Related]
4. Delayed cutaneous hypersensitivity reactions to tumor cell antigens and to nonspecific antigens. Prognostic significance in patients with lung cancer.
Wells SA; Burdick JF; Joseph WL; Christiansen CL; Wolfe WG; Adkins PC
J Thorac Cardiovasc Surg; 1973 Oct; 66(4):557-62. PubMed ID: 4755446
[No Abstract] [Full Text] [Related]
5. Delayed hypersensitivity-induced regression of human neoplasms.
Stjernswärd J; Levin A
Cancer; 1971 Sep; 28(3):628-40. PubMed ID: 4938247
[No Abstract] [Full Text] [Related]
6. Immunologic approaches to various types of cancer with the use of BCG and purified protein derivatives.
Klein E; Holtermann OA; Papermaster B; Milgrom H; Rosner D; Klein L; Walker MJ; Zbar B
Natl Cancer Inst Monogr; 1973 Dec; 39():229-42. PubMed ID: 4595323
[No Abstract] [Full Text] [Related]
7. Immunologic approaches to the management of primary and secondary tumors involving the skin and soft tissues: review of a ten-year program.
Klein E; Holtermann OA; Helm F; Rosner D; Milgrom H; Adler S; Stoll HL; Case RW; Prior RL; Murphy GP
Transplant Proc; 1975 Jun; 7(2):297-315. PubMed ID: 1093298
[No Abstract] [Full Text] [Related]
8. Melanoma-reactive human cytotoxic T lymphocytes derived from skin biopsies of delayed-type hypersensitivity reactions induced by injection of an autologous melanoma cell line.
Waanders GA; Rimoldi D; Liénard D; Carrel S; Lejeune F; Dietrich PY; Cerottini JC; Romero P
Clin Cancer Res; 1997 May; 3(5):685-96. PubMed ID: 9815737
[TBL] [Abstract][Full Text] [Related]
9. Delayed cutaneous hypersensitivity reaction in breast cancer patients.
Jain P; Khanna NN
J Indian Med Assoc; 1988 Jan; 86(1):5-7. PubMed ID: 3288701
[No Abstract] [Full Text] [Related]
10. High-dose recombinant interleukin-2 in advanced cutaneous T-cell lymphoma.
Marolleau JP; Baccard M; Flageul B; Rybojad M; Laroche L; Vérola O; Brandely M; Morel P; Gisselbrecht C
Arch Dermatol; 1995 May; 131(5):574-9. PubMed ID: 7741545
[TBL] [Abstract][Full Text] [Related]
11. Delayed-type hypersensitivity in patients with mycosis fungoides.
van der Harst-Oostveen CJ; van Vloten WA
Dermatologica; 1978; 157(3):129-35. PubMed ID: 150343
[TBL] [Abstract][Full Text] [Related]
12. The regression of an inflammatory skin lesion by the induction of a delayed hypersensitivity reaction. A case report.
Stewart TH; Tolnai G
Cancer; 1969 Jul; 24(1):117-21. PubMed ID: 5790282
[No Abstract] [Full Text] [Related]
13. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
[TBL] [Abstract][Full Text] [Related]
14. Hypersensitivity reactions at tumor sites.
Klein E
Cancer Res; 1969 Dec; 29(12):2351-62. PubMed ID: 5387265
[No Abstract] [Full Text] [Related]
15. [Immunologic reactivity of breast cancer patients].
Semiglazov VF; Kondrat'ev VB; Mar'enko AI; L'vovich EG; Sofronov BN
Vopr Onkol; 1978; 24(8):74-9. PubMed ID: 695430
[TBL] [Abstract][Full Text] [Related]
16. Desensitization. IV: Permeability changes during active and passive desensitization.
Baba T; Yoshida T; Cohen S
J Exp Pathol; 1984; 1(3):175-82. PubMed ID: 6599937
[TBL] [Abstract][Full Text] [Related]
17. Ambulatory arterial infusion in the treatment of primary and secondary skin cancer.
Sullivan RD
Proc Natl Cancer Conf; 1970; 6():543-52. PubMed ID: 4917734
[No Abstract] [Full Text] [Related]
18. A comparison of the hematogenous cell infiltrate evoked by lymphokine injection with that of delayed hypersensitivity reactions.
Franco MF; Kelly RH; Morley J
Am J Pathol; 1978 Oct; 93(1):117-35. PubMed ID: 696800
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous delayed hypersensitivity in patients with colorectal cancer: application of multi-test.
Papatheodorou K; Triantafillidis JK; Kogevinas M; Manoussakis K; Nicolakis D; Merikas E
Ital J Gastroenterol; 1994; 26(1):12-5. PubMed ID: 8025300
[TBL] [Abstract][Full Text] [Related]
20. Delayed cutaneous sensitivity reactions to extracts of autologous malignant melanoma: a second look.
Bluming AZ; Vogel CL; Ziegler JL; Kiryabwire JW
J Natl Cancer Inst; 1972 Jan; 48(1):17-24. PubMed ID: 4652371
[No Abstract] [Full Text] [Related]
[Next] [New Search]
